Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-02

FDA Approved: MICROGESTIN 1/20 — Supplemental Application (Dr.Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for Microgestin 1/20 (norethindrone acetate/ethinyl estradiol) from Dr. Reddy's Laboratories Inc., under the ANDA pathwa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MICROGESTIN 1/20 (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL)

Snippet

SUPPL AP for MICROGESTIN 1/20 (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL)